STORM Therapeutics is a pioneer in the field of RNA epigenetics. We are an emerging biotechnology company in Cambridge, UK, focused on developing small molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.

Biotechnology

STORM Therapeutics

Jerry McMahon

Marguerite Hutchinson

Yaara Ofir-Rosenfeld

Josi Holz

Byron Andrews

Matthew Fyfe

Margaret Daniel

Josefin-Beate Holz

Oliver Rausch

The Executive Management team at STORM Therapeutics is responsible for providing strategic direction and oversight to drive the company’s mission in RNA epigenetics. Comprising key leadership roles, including the CEO, CFO, and various board members, the team focuses on decision-making that shapes research priorities, fosters partnerships, and ensures financial sustainability, all aimed at advancing innovative therapies for cancer treatment.

Executive Management

Research and Development

Leadership Team

Executive Management

About

Team members

Other teams at STORM Therapeutics

Research and Development

Leadership Team